Mounjaro works by helping the body release insulin when blood sugar is high, remove excess sugar from the blood, stop the liver from making and releasing too much sugar, reduce how much food is eaten and slow down how quickly food leaves the stomach
Semaglutide and tirzepatide have their marketing authorizations, but neither is reimbursed in France for obesity as of May 2026, despite favorable opinions from the French National Authority for Health (HAS)
Clinical studies showed similar half-lives across age groups from younger adults through elderly patients
Featured: Elise Worthington, Four Corners reporter Subscribe to ABC News Daily on the ABC listen app
Patience at 0.25 mg pays dividends later
Large cohort studies have shown no increased risk compared to other metabolic medications (Douros et al., 2025)